Ligand Pharmaceuticals – Glucagon CVR (LGNXZ)
Market Closed
6 Aug, 20:00
OTC PINK OTC PINK Primary $
0. 00
-0
-4.7619%
$
40.08K Market Cap
23.93 P/E Ratio
- Div Yield
7 Volume
0 Eps
$ 0
Previous Close Want to track LGNXZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 1.84 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
LGNXZ Earnings Reports FAQ
What is the earnings per share (EPS) for LGNXZ?
The current EPS is 0.
What is the company's earnings growth rate?
Ligand Pharmaceuticals – Glucagon CVR has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Ligand Pharmaceuticals – Glucagon CVR has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Ligand Pharmaceuticals – Glucagon CVR are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LGNXZ at this time, as Ligand Pharmaceuticals – Glucagon CVR has no recent EPS data to calculate it.
